Cited 1 times in

Clinical characteristics and prognosis of patients with COVID-19 on mechanical ventilation undergoing continuous renal replacement therapy

Authors
 Dae-Eun Choi  ;  Duk Ki Kim  ;  Sunghoon Park  ;  Su Hwan Lee  ;  Onyu Park  ;  Taehwa Kim  ;  Hye Ju Yeo  ;  Jin Ho Jang  ;  Woo Hyun Cho  ;  Song I Lee Korean Intensive Care Study Group 
Citation
 PLOS ONE, Vol.19(4) : e0297344, 2024-04 
Journal Title
PLOS ONE
Issue Date
2024-04
MeSH
Acute Kidney Injury* ; COVID-19* / complications ; COVID-19* / therapy ; Continuous Renal Replacement Therapy* ; Coronavirus Infections* / complications ; Coronavirus* ; Humans ; Intensive Care Units ; Multiple Organ Failure / complications ; Prognosis ; Renal Replacement Therapy ; Respiration, Artificial ; Respiratory Insufficiency* / complications ; Respiratory Insufficiency* / therapy ; Retrospective Studies
Abstract
Background The coronavirus disease (COVID-19) pandemic has significantly strained global healthcare, particularly in the management of patients requiring mechanical ventilation (MV) and continuous renal replacement therapy (CRRT). This study investigated the characteristics and prognoses of these patients. Methods This multicenter retrospective cohort study gathered data from patients with COVID-19 across 26 medical centers. Logistic analysis was used to identify the factors associated with CRRT implementation. Results Of the 640 patients with COVID-19 who required MV, 123 (19.2%) underwent CRRT. Compared to the non-CRRT group, the CRRT group was older and exhibited higher sequential organ failure assessment scores. The incidence of hypertension, diabetes, cardiovascular disease, chronic neurological disease, and chronic kidney disease was also higher in the CRRT group. Moreover, the CRRT group had higher intensive care unit (ICU) (75.6% vs. 26.9%, p < 0.001) and in-hospital (79.7% vs. 29.6%, p < 0.001) mortality rates. CRRT implementation was identified as an independent risk factor for both ICU mortality (hazard ratio [HR]:1.833, 95% confidence interval [CI]:1.342-2.505, p < 0.001) and in-hospital mortality (HR: 2.228, 95% CI: 1.648-3.014, p < 0.001). Refractory respiratory failure (n = 99, 19.1%) was the most common cause of death in the non-CRRT death group, and shock with multiorgan failure (n = 50, 40.7%) was the most common cause of death in the CRRT death group. Shock with multi-organ failure and cardiac death were significantly more common in the CRRT death group, compared to non-CRRT death group. Conclusion This study indicates that CRRT is associated with higher ICU and in-hospital mortality rates in patients with COVID-19 who require MV. Notably, the primary cause of death in the CRRT group was shock with multi-organ failure, emphasizing the severe clinical course for these patients, while refractory respiratory failure was most common in non-CRRT patients. © 2024 Choi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Files in This Item:
T202404933.pdf Download
DOI
10.1371/journal.pone.0297344
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Lee, Su Hwan(이수환) ORCID logo https://orcid.org/0000-0002-3487-2574
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/200396
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links